| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.63B | 40.13B | 38.49B | 39.22B | 38.91B | 34.15B |
| Gross Profit | 9.38B | 9.94B | 9.36B | 9.60B | 8.71B | 6.46B |
| EBITDA | 9.16B | 8.25B | 8.32B | 8.38B | 8.23B | 12.79B |
| Net Income | 3.76B | 4.04B | 3.03B | 3.11B | 2.66B | 5.97B |
Balance Sheet | ||||||
| Total Assets | 119.88B | 130.30B | 122.69B | 114.53B | 111.17B | 108.75B |
| Cash, Cash Equivalents and Short-Term Investments | 7.54B | 8.83B | 8.86B | 5.78B | 8.37B | 8.78B |
| Total Debt | 41.67B | 42.52B | 43.19B | 39.23B | 39.79B | 37.98B |
| Total Liabilities | 61.89B | 68.07B | 65.11B | 60.15B | 61.52B | 61.78B |
| Stockholders Equity | 57.99B | 62.23B | 57.57B | 54.38B | 49.64B | 46.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.44B | -675.00M | -1.10B | -2.21B | -5.57B |
| Operating Cash Flow | 0.00 | 8.02B | 5.90B | 8.51B | 5.16B | 6.14B |
| Investing Cash Flow | 0.00 | -5.36B | -7.81B | -10.11B | -6.72B | -4.17B |
| Financing Cash Flow | 0.00 | -1.67B | 3.30B | -1.28B | 1.14B | 791.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥313.65B | 13.49 | ― | 1.61% | 1.51% | 14.84% | |
60 Neutral | ¥42.42B | 11.08 | ― | 2.17% | 4.27% | 33.45% | |
58 Neutral | ¥609.01B | 15.20 | 8.51% | 2.96% | -0.94% | -26.46% | |
58 Neutral | ¥220.46B | 7.11 | 12.70% | 1.68% | 6.91% | 58.68% | |
54 Neutral | ¥19.31B | 13.17 | ― | 0.81% | 5.49% | 29.14% | |
50 Neutral | ¥18.43B | 16.20 | ― | 1.33% | 11.16% | -16.05% |